TNFRSF10A and myelodysplastic syndrome: Also, the death receptor ligand TRAIL and its receptors TRAILR1 and TRAILR2 are increased in bone marrow of MDS patients and hemopoietic progenitor cells from MDS patients are more sensitive to TRAIL-mediated apoptosis [61], [62].